MRI-guided procedure sets new benchmarks in cardiac ablation
Imricor Medical Systems has initiated a first-in-human trial for its real-time MRI-guided ventricular ablation, marking several world-first milestones.
The inaugural case, performed at Amsterdam University Medical Centre, used Imricor’s NorthStar Mapping System and involved treatment of both right- and left-sided premature ventricular complexes (PVCs). It is the first time a ventricular ablation and left-sided ablation were performed under real-time MRI guidance.
MRI allows better visualization of heart anatomy and surrounding structures during ablation, surpassing X-ray capabilities. Imricor’s Vision-MR catheter, designed for MRI use, aims to deliver faster, safer, and more effective treatment for arrhythmias.
Already approved in Europe for type 1 atrial flutter, Imricor is planning regulatory expansion into the U.S. and Australia, with broader indications in development.
Follow MEDWIRE.AI for breakthroughs in cardiac imaging and ablation.
